Issues
-
Cover Image
Cover Image
ABOUT THE COVER
The cover image depicts confocal light microscopy of tumor-bearing mouse foot pad tissue. Myelinated epidermal nerve fibers have been labeled with S-100 antibody (red). FITC-Phalloidin reveals actin structure in the skin (green), whereas Hoechst indicates cell nuclei (blue). Cisplatin therapy is associated with reduced numbers of large myelinated epidermal nerve fibers in the skin, leading to loss of sensation. Here, Zhu and colleagues demonstrate that the Rho kinase (ROCK) inhibitor Y-27632 protects myelinated epidermal nerve fibers from cisplatin-induced impairment in mouse foot pad tissue. See the Highlight on page 1775 and the article on page 1910 for more information. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Molecular Cancer Research
Table of Contents
Highlights
Review
Cancer Genes and Networks
AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells
Cancer “-omics”
Cell Fate Decisions
Metabolism
New Horizons in Cancer Biology
RNA Biology
Signal Transduction and Functional Imaging
Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models
Correction
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.